Join us for ECCP 2012 and BIO-Europe in November!
We cordially invite you to attend ECCP 2012, November 11th in Hamburg – the 4th European oncology B2B meeting for biotech, pharma, investors, clinicians and academia. ECCP 2012 can easily be combined with Europe’s largest partnering conference, BIO-Europe, on 12-14 November 2012, which also takes place in Hamburg.
“ECCP 2012 is listed as additional program for BIO-Europe, so we expect there will be a beneficial synergy between the two events," says Jutta Heix, who is International Advisor at Oslo Cancer Cluster and organising the event in partnership with the French cancer cluster Cancer-Bio-Santé. “Bringing ECCP to Hamburg as a satellite event to BIO-Europe will surely attract new faces to the lively oncology network and maximize the participants’ partnering success.”
Research on Top of Europe
Whether you are planning to intensify your collaborations with the European oncology sector, or looking for venture capital or new business opportunities, Hamburg is the place to be during early November 2012. In addition to ECCP - Norway, Sweden, Denmark and Finland will showcase the R&D and innovation strength in the Nordics to a top-level international audience during BIO-Europe.
“The country seminar “Research on Top of Europe” should increase the awareness of the unique collaboration opportunities offered by the Nordic countries and could also stimulate to new partnerships,” says coordinator Peter Frank, ScanBalt. “Selected innovation milieus in the four countries will be presented at the joint country seminar on November 12th.”
Combine ECCP with BIO-Europe
If you choose to combine ECCP and BIO-Europe, you will benefit from discounts on both registrations. NOTE! To claim your ECCP-discount when you register for BIO-Europe, you need to write “ECCP2012 participant” in the comment field.
ECCP offers a vital networking arena for the international oncology community and is the direct result of the close collaboration between two of Europe’s strongest cancer clusters, the French Cancer-Bio Santé Cluster and the Norwegian Oslo Cancer Cluster. The key goal of ECCP is building partnerships to accelerate innovation in cancer treatment.
The 3rd ECCP in 2011 attracted 445 participants from 20 countries. The delegates benefited from 640 prescheduled one-on-one meetings. There were 1800 formal and informal contacts reported and close to 40% of the participants estimated two agreements resulting from their attendance. 97% of the participants were very satisfied or satisfied with the program and enjoyed excellent networking, and 89% stated they were planning to attend ECCP again in 2012.